Docetaxel Trihydrate & Anhydrous IP / USP / EP
Docetaxel is a semi-synthetic taxane microtubule inhibitor. Available in Trihydrate (CAS 148408-66-6, C43H53NO14·3H2O, MW 861.93 g/mol) and Anhydrous (CAS 114977-28-5, C43H53NO14, MW 807.88 g/mol) forms for breast, NSCLC, prostate, gastric, and head/neck cancers.
Direct Procurement Quote
Fill details to receive commercial terms and Certificate of Analysis (CoA).
Technical Specifications Summary
Formulation & Industry Applications
Related Ingredients
Explore complementary ingredients in Oncology APIs Portfolio: